Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-05

Clinical Trial Update: Misoprostol in the Prevention of Postpartum Haemorrhage [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating misoprostol for the prevention of postpartum hemorrhage is in progress, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MISOPROSTOL (Misoprostol)

Snippet

Sponsor: The University of The West Indies | Conditions: Postpartum Hemorrhage | Phase 3 | Status: UNKNOWN